Telephone Enhancement Procedure for Continuing Care - 1

This study has been completed.

First Received: August 12, 2003 Last Updated: June 18, 2009 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	Duke University
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00067171

Purpose

The purpose of this study is to test a feasibility study of a telephone enhancement procedure (TELE) to improve participation in continuing care activities.

Condition	Intervention	Phase
Substance-Related Disorders	Behavioral: Behavior Therapy	Phase III

Study Type:	Interventional
Study Design:	Randomized
Official Title:	Telephone Enhancement Procedure (TELE) for Continuing Care

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Treatment compliance, drug and alcohol astinence

Estimated Enrollment:	339
Study Start Date:	January 2003
Study Completion Date:	January 2004
Primary Completion Date:	January 2004 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Residential substance abuse treatment patients who reside within the pre-specified catchment area who complete continuing care plans prior to discharge.
Voluntary admit to residential treatment center; substance abuse or dependence; reside in targeted counties; and may be reached by telephone.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00067171

Locations

United States, Michigan
James Gilmore Jr. Treatment Center
Kalamazoo, Michigan, United States, 49408
United States, North Carolina
Julian F. Keith
Black Mountain, North Carolina, United States, 28711
Walter B. Jones, ADATC
Greenville, North Carolina, United States, 27834
United States, South Carolina
Morris Village Alcohol & Drug Treatment Center
Columbia, South Carolina, United States, 29203

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Duke University

Investigators

Principal Investigator:

Robert Hubbard, Ph.D.

Duke University

More Information

Additional Information:

Data Elements This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	NIDA-CTN-0011-1
Study First Received:	August 12, 2003
Last Updated:	June 18, 2009
ClinicalTrials.gov Identifier:	NCT00067171 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on November 30, 2009